SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019687-09-003790
Filing Date
2009-10-27
Accepted
2009-10-27 08:16:59
Documents
3
Period of Report
2009-10-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT peregrine_8k-102209.htm 8-K 41840
2 INCENTIVE STOCK OPTION AWARD AGREEMENT peregrine_8k-ex0414.htm EX-4.14 61760
3 NON-QUALIFIED STOCK OPTION AWARD AGREEMENT peregrine_8k-ex0415.htm EX-4.15 61306
  Complete submission text file 0001019687-09-003790.txt   166722
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 091138086
SIC: 2835 In Vitro & In Vivo Diagnostic Substances